Clinical trial
Phase IV Study on QoL in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide
NCT01430546 is registered in ClinicalTrials.gov with Hareth Nahi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV Study on QoL in Relapsed/Refractory Multiple Myeloma When Treated With Lenalidomide
- Lead sponsor
- Hareth Nahi
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- Not reported
- Enrollment
- 133 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.